Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
All Products
Displaying products alphabetically by name (O)
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
|---|
Cat.No. |
Product Name / Activity |
| 2797 | O-1602 Potent GPR55 receptor agonist |
| 2288 | O-1918 Silent antagonist for putative abnormal-CBD (Cat. No. 1297) receptor |
| 1655 | O-2050 Putative CB1 silent antagonist; displays mixed activity at CB receptors |
| 1446 | O-2093 Inhibitor of anandamide uptake |
| 2680 | O-2545 hydrochloride High affinity, water-soluble CB1/CB2 agonist |
| 0606 | OBAA Phospholipase A2 inhibitor |
| 2445 | Obestatin (rat) Endogenous anorexigenic peptide |
| 4664 | Obtustatin Potent and selective α1β1 inhibitor |
| 1291 | Ochratoxin A Stimulates SERCA-ATP-dependent Ca2+ pump activity |
| 4410 | Ocinaplon GABAA modulator; anxiolytic |
| 0605 | (±)-Octanoylcarnitine chloride Intermediate in lipid metabolism |
| 4225 | OctMAB Dynamin inhibitor |
| 2242 | Octopamine hydrochloride Invertebrate biogenic amine: activates β3 adrenoceptors |
| 1818 | Octreotide sst2, sst3 and sst5 agonist |
| 0880 | ODQ Selective inhibitor of NO-sensitive guanylyl cyclase |
| 0607 | 17-ODYA LTB-ω-Hydroxylase inhibitor |
| 2710 | OGT 2115 Antiangiogenic. Heparanase inhibitor |
| 1136 | Okadaic acid Protein phosphatase 1 and 2A inhibitor |
| 4349 | Olanzapine 5-HT2A/D2 antagonist; atypical antipsychotic |
| 1641 | OLDA Potent, selective endogenous TRPV1 agonist |
| 0878 | Oleamide CB1 receptor agonist |
| 3854 | 1-Oleoyl lysophosphatidic acid sodium salt Endogenous agonist of LPA1 and LPA2 |
| 1484 | Oleylethanolamide GPR55 agonist. Also PPARα agonist |
| 4110 | Oligomycin A Inhibitor of mitochondrial ATPase |
| 4616 | Olmesartan Potent AT1 antagonist; metabolite of Olmesartan medoxomil (Cat. No. 4620) |
| 4620 | Olmesartan medoxomil Selective non-peptide AT1 antagonist; prodrug of Olmesartan |
| 1284 | Olomoucine Cyclin-dependent kinase inhibitor |
| 4241 | Olopatadine hydrochloride H1 antagonist; ocular antiallergic agent |
| 0934 | Olvanil Potent vanilloid receptor agonist |
| 1797 | OMDM-2 Potent inhibitor of anandamide uptake |
| 2583 | Omeprazole H+,K+-ATPase inhibitor |
| 4376 | 5-OMe-UDP trisodium salt Potent P2Y6 agonist |
| 3427 | Oncrasin 1 Induces abnormal nuclear aggregation of PKCι; proapoptotic |
| 2891 | Ondansetron hydrochloride Selective 5-HT3 antagonist |
| 3026 | ONO 1078 Selective CysLT1 antagonist |
| 4530 | ONO 2506 Inhibits S100B synthesis; neuroprotective |
| 2628 | ONO 4817 Broad spectrum MMP inhibitor |
| 3924 | OPC 21268 Orally active vasopressin V1 antagonist |
| 0483 | OR-486 Catechol O-methyltransferase inhibitor |
| 1455 | Orexin A (human, rat, mouse) Endogenous agonist at OX1 and OX2 |
| 1456 | Orexin B (human) Endogenous agonist at OX1 and OX2 |
| 1457 | Orexin B (mouse) Endogenous agonist at OX1 and OX2 |
| 2142 | [Ala11,D-Leu15]-Orexin B Potent, selective OX2 receptor agonist |
| 3585 | Org 12962 hydrochloride Selective 5-HT2C agonist |
| 2738 | Org 20599 Positive allosteric modulator and direct agonist of GABAA receptors |
| 4035 | Org 24598 lithium salt Selective GlyT1 inhibitor |
| 4782 | Org 25543 hydrochloride Potent and selective GlyT2 inhibitor |
| 2957 | Org 27569 Potent allosteric CB1 modulator |
| 3540 | Orlistat Pancreatic, gastric and carboxylester lipase inhibitor; antiobesity and antihypercholesterolemic activity |
| 3932 | Orphanin FQ (1-11) Potent NOP agonist; displays analgesic properties |
| 2599 | OSU 6162 hydrochloride Dopamine stabilizer |
| 1076 | Ouabain Na+,K+-ATPase inhibitor |
| 4160 | 22-Oxacalcitriol Non-calcemic vitamin D3 (Cat. No. 4156) analog |
| 2623 | Oxaliplatin DNA cross-linking antitumor agent |
| 3864 | Oxcarbazepine Anticonvulsant; inhibits Na+ channel activity |
| 1796 | 5-Oxo-ETE Oxoeicosanoid receptor agonist |
| 0843 | Oxotremorine sesquifumarate Muscarinic agonist |
| 1067 | Oxotremorine M Muscarinic agonist |
| 3604 | (5Z)-7-Oxozeaenol Potent and selective TAK1 MAPKKK inhibitor |
| 3288 | Oxprenolol hydrochloride Non-selective β antagonist |
| 3958 | Oxycodone hydrochloride μ-opioid receptor agonist |
| 1142 | Oxymetazoline hydrochloride α1A agonist |
| 2094 | Oxyntomodulin Endogenous gut peptide; modulates feeding and metabolism |
| 1910 | Oxytocin Involved in uterine contraction and lactation |
| 1510 | Ozagrel hydrochloride Selective thromboxane A2 synthetase inhibitor |
Products by Catalog Number
[top]
Quick Order
Find multiple products by catalog number
New Product E-alerts
Sign up for email updates from Tocris
20% Discount*
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.